Presentation is loading. Please wait.

Presentation is loading. Please wait.

BY NKEM UMEOKOLI MSc Neuropharmacology University of East London

Similar presentations


Presentation on theme: "BY NKEM UMEOKOLI MSc Neuropharmacology University of East London"— Presentation transcript:

1 BY NKEM UMEOKOLI MSc Neuropharmacology University of East London
GALANIN BY NKEM UMEOKOLI MSc Neuropharmacology University of East London

2 Galanin is a 29 amino acid neuro-peptide isolated from porcine intestine.
It shows many interesting physiological and behavioural actions which may be relevant to some disease states and clinical therapeutics.

3 Named from the first and last amino acids in its porcine sequence - Glycine and Alanine.
The first 15 amino acids in its peptide sequence is conserved in a variety of species including Humans, rats, pigs, cows, dogs, chickens and alligators.

4 NMR analysis of Rat galanin indicates a secondary structure of two alpha-helices interrupted by a bend in the proline-13 amino acid residue.

5 Galanin is widely distributed in both the central and the peripheral nervous systems.
In the CNS: hypothalamus/hippocampus, brain stem, spinal cord. In the peripheral organs: pancreas, adrenal gland, gastrointestinal tract, genital tract, urinary bladder

6 Galanin binds to and acts on G-protein coupled receptors.
Only one galanin receptor subtype has been cloned so far - GalR1. Pharmacological evidence suggests more than one receptor subtype exists.

7 Purified galanin receptors from rat and human brain show a single polypeptide of 54-60 kDa.

8 The 1st antagonist for the galanin receptor has been synthesised called M15 or Galantide.
Binding of the antagonist to the galanin receptor is nM concentration.

9 Physiological functions of Galanin
In Alzheimer’s disease galanin is elevated galanin inhibits acetylcholine release Galanin receptor antagonists may enhance cholinergic transmission.

10 Galanin stimulates food consumption release of luteinising hormone prolactin release growth hormone

11 Galanin serves an antinociceptive function in the spinal cord.
Galanin agonists may be clinically useful in potentiating the analgesic actions of morphine.

12 Galanin inhibits insulin release, therefore causes hyperglycemia.
Galanin may be involved in some forms of human obesity.

13 In conclusion Galanin is a 29 amino acid neuro-peptide has inhibitory actions Exerts biological effects in mammals such as feeding, insulin release and growth hormone release. Is involved in the pathogenesis of Alzheimer’s disease and in antinociception.


Download ppt "BY NKEM UMEOKOLI MSc Neuropharmacology University of East London"

Similar presentations


Ads by Google